Skip to search formSkip to main contentSkip to account menu

Faah protein, rat

Known as: fatty acid amide hydrolase, rat 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

fatty acid amide hydrolase

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Targeting fatty acid amide hydrolase and transient receptor potential vanilloid‐1 simultaneously to modulate colonic motility and visceral sensation in the mouse: A pharmacological intervention with…
Endocannabinoid anandamide (AEA) inhibits intestinal motility and visceral pain, but it may also be proalgesic through transient… 
Highly Cited
2016
Highly Cited
2016
What failed BIA 10–2474 Phase I clinical trial? Global speculations and recommendations for future Phase I trials
One of the major advances in this field was the generation of fatty acid amide hydrolase (FAAH) inhibitors.[3,4] FAAH hydrolyses… 
2011
2011
Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 1: identification of 7-azaspiro[3.5]nonane and 1-oxa-8-azaspiro[4.5]decane as lead scaffolds.
Highly Cited
1998
Highly Cited
1998
Comparative characterization of a wild type and transmembrane domain-deleted fatty acid amide hydrolase: identification of the transmembrane domain as a site for oligomerization.
Fatty acid amide hydrolase (FAAH) is an integral membrane protein responsible for the hydrolysis of a number of primary and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)